ArticleMolecular therapy oncolytics2016

Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist.

Barbara Volz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.